CSL112, a Novel Formulation of Apolipoprotein A-I Exhibits Potent Anti-Inflammatory Activity in Whole Blood

被引：0
|
作者：
Diditchenko, Svetlana [1 ]
Schenk, Sabrina [2 ]
Pragst, Ingo [3 ]
Wright, Samuel [4 ]
机构：
[1] CSL Behring AG, Res & Dev, Bern, Switzerland
[2] CSL Behring GmbH, Res & Dev, Marburg, Germany
[3] CSL Behring GmbH, Preclin Rsch & Dev, Marburg, Germany
[4] CSL Ltd, Cardiovasc Therapeut, Parkville, Vic, Australia
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Acute coronary syndromes; Apolipoproteins; Inflammation; HDL elevating therapies; Arteriosclerosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11838
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Novel Nonradioactive Method Documents Strong Elevation of the Cholesterol Esterification Rate by CSL112, a Novel Formulation of Human Apolipoprotein A-I
    Boerema, David J.
    Martin, Kirstee L.
    Meikle, Peter J.
    Wright, Samuel D.
    Gille, Andreas
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
  • [2] Infusion of CSL112, a novel formulation of human apolipoprotein A-I, in healthy subjects removes tissue cholesterol and directs its clearance
    Gille, A.
    Wright, S.
    Easton, R.
    Shear, C.
    EUROPEAN HEART JOURNAL, 2013, 34 : 350 - 350
  • [3] Evaluation of Potential Antiplatelet Effects of CSL112, a Novel Formulation of Human Apolipoprotein A-I: Results From a Phase 2a Study
    Gurbel, Paul A.
    Bliden, Kevin P.
    D'Andrea, Denise M.
    Henderson, Karen W.
    Alexander, John H.
    Tantry, Udaya S.
    Shear, Charles
    Tricoci, Pierluigi
    CIRCULATION, 2013, 128 (22)
  • [4] Distribution of Anti-inflammatory Activity During Remodeling of High Density Lipoprotein: Studies With CSL112
    Diditchenko, Svetlana A.
    Navdaev, Alexei V.
    Spycher, Martin O.
    Wright, Samuel D.
    CIRCULATION, 2015, 132
  • [5] Infusion of human apolipoprotein A-I (CSL112) promotes several aspects of reverse cholesterol transport
    Mathias, Rommel
    Velkoska, Elena
    Diditchenko, Svetlana
    Greene, Brandon
    Tan, Xiahui
    Navdaev, Alexey
    Collins, Heidi
    Adelman, Steven
    Young, Kyal
    Gille, Andreas
    Duffy, Danielle
    Gibson, Michael
    Pelzing, Matthias
    Kingwell, Bronwyn
    CIRCULATION, 2024, 150
  • [6] THE EFFECT OF CSL112 (APOLIPOPROTEIN A-I, HUMAN) ON CHOLESTEROL EFFLUX CAPACITY: A CROSS-STUDY COMPARISON
    Zheng, Bo
    Goto, Shinya
    Clementi, Regina
    Feaster, John
    Duffy, Danielle
    Dalitz, Penelope
    Airey, Jolanta
    Roberts, John
    Korjian, Serge
    Gibson, Michael C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1026 - 1026
  • [7] Anti-inflammatory mechanism of Apolipoprotein A-I
    Tao, Xia
    Tao, Ran
    Wang, Kaiyang
    Wu, Lidong
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [8] The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction
    Gibson, C. Michael
    Kerneis, Mathieu
    Yee, Megan K.
    Daaboul, Yazan
    Korjian, Serge
    Mehr, Ali Poyan
    Tricoci, Pierluigi
    Alexander, John H.
    Kastelein, John J. P.
    Mehran, Roxana
    Bode, Christoph
    Lewis, Basil S.
    Mehta, Ravindra
    Duffy, Danielle
    Feaster, John
    Halabi, Majdi
    Angiolillo, Dominick J.
    Duerschmied, Daniel
    Ophuis, Ton Oude
    Merkely, Bela
    AMERICAN HEART JOURNAL, 2019, 208 : 81 - 90
  • [9] PHARMACOKINETICS AND SAFETY OF A NOVEL APOLIPOPROTEIN A-I THERAPY, CSL112, IN ADULTS WITH MODERATE RENAL IMPAIRMENT (RI) AND NORMAL RENAL FUNCTION
    Tortorici, M. A.
    Duffy, D.
    Zhou, M.
    Evans, R.
    Feaster, J.
    D'Andrea, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S90 - S90
  • [10] Safety and Pharmacokinetics of a Novel Formulation of Human Apolipoprotein A-I (CSL112) in Healthy Subjects: Results of a Placebo-Controlled, Randomized Multiple Ascending Dose Study
    Easton, Rachael
    Tremper, Louise
    Shear, Charles
    CIRCULATION, 2012, 126 (21)
12345